Figure 1.

Effect of changes in treatment success rates and costs per patient registered on the cost-effectiveness of the family-based DOTS and community-based DOTS strategies. The figure presents the effect of changes in the treatment success rates (%) and costs per patient (US$) under the CBD strategy on the balance of cost-effectiveness between the FBD and CBD strategies. Note: The axes cross at the current treatment success rate (83%) and costs per patient (US$76.2) for the community-based DOTS strategy.